Wedbush covered Colony NorthStar (NYSE:CLNS), reducing its stock price target to $17.25 today
- Updated: April 21, 2017
In a report issued 04/21/2017 Wedbush reduced the stock price target of Colony NorthStar (NYSE:CLNS) from $26.00 to $17.25 indicating a possible upside of 0.31%.
Only yesterday Colony NorthStar (NYSE:CLNS) traded 0.61% higher at $13.14. The company’s 50-day average is $13.10 and its two hundred day average is $13.97. With the last stock price close down -5.95% from the 200-day moving average, compared to the S&P 500 which has increased 0.03% over the same period. Trade Volume was down over the average, with 2,560,180 shares of CLNS changing hands under the typical 3,504,130
With a total market value of $0, Colony NorthStar has P/E ratio of 22.73 with a 52 week low of $9.70 and a 52 week high of $16.08 .
General Information About Colony NorthStar (NYSE:CLNS)
Colony NorthStar, Inc. is a diversified equity real estate investment trust (REIT). The Company combines a portfolio of real assets across the world, which are managed with a global real estate investment manager. The Company has property holdings in the healthcare, industrial and hospitality sectors, opportunistic equity and debt investments, and an embedded institutional and retail investment management business. In addition, the Company owns NorthStar Securities, LLC, a captive broker-dealer platform which raises capital in the retail market. The Company acquires, develops and operates industrial properties in metropolitan markets throughout the United States with a focus on light industrial buildings. The Company provides investment management services and offers investment products while serving as a fiduciary to a set of institutional and individual investors.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.